European Equities Traded in the US as American Depositary Receipts Track Higher in Friday Trading

MT Newswires Live
Yesterday

European equities traded in the US as American depositary receipts were trending higher late Friday morning, rising 0.59% to 1,883.71 on the S&P Europe Select ADR Index, which has shed close to 2% for the week so far.

From continental Europe, the gainers were led by telecommunications company Nokia (NOK) and biopharmaceutical company Cellectis (CLLS), which rose 3.1% and 2.9%. respectively. They were followed by semiconductor company Sequans Communications (SQNS) and telecommunications company Ericsson (ERIC), which were up 2.7% and 1.6%, respectively.

The decliners from continental Europe were led by accommodations booking site trivago (TRVG) and biopharmaceutical company DBV Technologies (DBVT), which fell 6.1% and 2.7%, respectively. They were followed by pharmaceutical company Sanofi (SNY) and biopharmaceutical company argenx (ARGX), which were down 1.9% and 1.5%, respectively.

The gainers from the UK were led by telecommunications operator Vodafone Group (VOD) and utilities company National Grid (NGG), which advanced 3% and 1.8%, respectively. They were followed by mining company BHP Group (BHP) and software firm Endava (DAVA), which increased 1.2% and 0.8%, respectively.

The decliners from the UK and Ireland were led by biotech firm Trinity Biotech (TRIB) and pharmaceutical company Silence Therapeutics (SLN), which lost 17% and 2.3%, respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and biotech firm Autolus Therapeutics (AUTL), which dropped 2.2% each.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10